220 related articles for article (PubMed ID: 18829481)
1. Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation.
Huang HY; West RB; Tzeng CC; van de Rijn M; Wang JW; Chou SC; Huang WW; Eng HL; Lin CN; Yu SC; Wu JM; Lu CC; Li CF
Clin Cancer Res; 2008 Oct; 14(19):6023-32. PubMed ID: 18829481
[TBL] [Abstract][Full Text] [Related]
2. Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors.
Möller E; Mandahl N; Mertens F; Panagopoulos I
Genes Chromosomes Cancer; 2008 Jan; 47(1):21-5. PubMed ID: 17918257
[TBL] [Abstract][Full Text] [Related]
3. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T
Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
7. Malignant diffuse-type tenosynovial giant cell tumors: a series of 7 cases comparing with 24 benign lesions with review of the literature.
Li CF; Wang JW; Huang WW; Hou CC; Chou SC; Eng HL; Lin CN; Yu SC; Huang HY
Am J Surg Pathol; 2008 Apr; 32(4):587-99. PubMed ID: 18301053
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic characterization of tenosynovial giant cell tumors.
Brandal P; Bjerkehagen B; Heim S
Neoplasia; 2004; 6(5):578-83. PubMed ID: 15548367
[TBL] [Abstract][Full Text] [Related]
9. Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.
Tsuda Y; Hirata M; Katayama K; Motoi T; Matsubara D; Oda Y; Fujita M; Kobayashi H; Kawano H; Nishida Y; Sakai T; Okuma T; Goto T; Ogura K; Kawai A; Ae K; Anazawa U; Suehara Y; Iwata S; Miyano S; Imoto S; Shibata T; Nakagawa H; Yamaguchi R; Tanaka S; Matsuda K
Int J Cancer; 2019 Dec; 145(12):3276-3284. PubMed ID: 31107544
[TBL] [Abstract][Full Text] [Related]
10. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
[TBL] [Abstract][Full Text] [Related]
11. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
12. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
[TBL] [Abstract][Full Text] [Related]
13. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.
Lien HC; Lin CW; Mao TL; Kuo SH; Hsiao CH; Huang CS
J Pathol; 2004 Oct; 204(2):131-9. PubMed ID: 15376261
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
[TBL] [Abstract][Full Text] [Related]
15. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
[TBL] [Abstract][Full Text] [Related]
17. A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor.
Lipplaa A; Meijer D; van de Sande MAJ; Gelderblom H; Bovée JVMG; Mei H; Szuhai K
Genes Chromosomes Cancer; 2023 Apr; 62(4):223-230. PubMed ID: 36504457
[TBL] [Abstract][Full Text] [Related]
18. Cyclin A is essential for the p53-modulated inhibition from benzo(a)pyrene toxicity in A549 cells.
Wang Z; Qi Y; Chen Q; Yang D; Tang S; Jin X; Gao J; Fu J; Zhou Z; Wang J; Xiao X
Toxicology; 2009 Feb; 256(1-2):1-6. PubMed ID: 19027820
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.
Cheng SH; Ng MH; Tsang KS; Lau KM; Chan JC; Liu HS; Chu RW; Poon CS; Ng HK
Int J Oncol; 2004 May; 24(5):1141-8. PubMed ID: 15067335
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.
Lindahl T; Landberg G; Ahlgren J; Nordgren H; Norberg T; Klaar S; Holmberg L; Bergh J
Carcinogenesis; 2004 Mar; 25(3):375-80. PubMed ID: 14633656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]